Two decades after a breast cancer vaccine trial, every participant is still alive—an astonishing result for metastatic disease. Scientists found their immune systems retained long-lasting memory cells primed to recognize cancer. By enhancing a key immune signal called CD27, researchers dramaticall y improved tumor elimination in lab studies. The findings suggest cancer vaccines may have been missing a crucial ingredient all along. ...read more read less